We know pharmacists because we are pharmacists
At PTCE, our team includes pharmacists with expertise across various disease states and practice settings. They are committed to developing high-quality CE activities for pharmacy professionals to enhance their knowledge, competence, and skills so they can offer the highest level of pharmacy care to the patients they serve.
Already Registered? Log In Here
Browse All Free Pharmacy Activities
Outsmart the Algorithm: Combatting Misinformation at the Pharmacy Counter
Monday, July 22, 2026 | 1:00 PM & 8:00 PM
Navigating Asparaginase-Based Therapies in Adult, Adolescent, and Young Adult Acute Lymphoblastic Leukemia: Evidence-Based Guidance for the Oncology Pharmacist
1.25 Credit / Hematology, Hematologic Cancer
Personalizing Breast Cancer Care: Pharmacist Strategies for Optimizing Oral Therapy Outcomes
1.5 Credit / Breast Cancer
Optimizing Care for Patients With Lupus Nephritis
1.5 Credit / General Pharmacy
Wake Up to Change: New Targets and Therapeutic Strategies in Narcolepsy
1.5 Credit / Dermatology
Improving the Identification and Management of Fibrosing Interstitial Lung Diseases Through the Power of the Multidisciplinary Care Team
1.5 Credit / Dermatology
Advancing Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through Specialty Pharmacy Support
1.5 Credit / Immunology
Applying Value-Based Principles in ATTR-CM Care: Optimizing Identification, Therapy Selection, and Patient Access
1.5 Credit / Cardiology
On the Pulse of Progress: Applying Ovarian Cancer Advances Across the Pharmacy Spectrum
1.5 Credits / Gynecologic Cancer, Oncology, Women's Health
Optimizing Specialty Pharmacy Practice in HER2-Altered Non-Small Cell Lung Cancer: Testing, Treatment, and Access
1.5 Credit / Immunology
Pipeline to Practice in Platinum-Resistant Ovarian Cancer: What's New, What's Next, and How to Prepare
1.0 Credit / Gynecologic Cancer, Oncology, Women's Health
TL1A Inhibitors in Inflammatory Bowel Disease: New Clinical Insights and Access Considerations for Managed Care and Specialty Pharmacy
1.5 Credit / Immunology
Enhancing Patient Outcomes in Metastatic Colorectal Cancer: Equipping Community, Veterans Affairs, and Oncology Pharmacists to Navigate Care in the Third-Line Setting and Beyond
Tuesday, June 30, 2026 | 1:00 PM & 8:00 PM EDT
Navigating Complexities in Chronic Lymphocytic Leukemia Therapy: A Practical Guide for Community Oncology Pharmacists
0.75 Credit / Oncology
Advancing Pharmacist-Led Care in Chronic Myeloid Leukemia: Bridging Knowledge and Practice Gaps to Optimize Tyrosine Kinase Inhibitor Management and Patient Adherence
0.75 Credit / Oncology
Advancing Community Oncology Practice: Pharmacist-Led Strategies for Biomarker-Driven Treatment in Non–Small Cell Lung Cancer
0.75 Credit / Oncology
Communication in Action: Empowering Community Oncology Pharmacists to Optimize Prostate Cancer Care Across Urology and Oncology
0.75 Credit / Oncology
The Art of the Possible: Strengthening the Community Pharmacist’s Involvement in Operational Workflows for Bispecific Antibody Therapy in Non-Hodgkin Lymphoma
0.75 Credit / Oncology
Targeting Genomic Drivers to Optimize ROS1-Directed Therapy in NSCLC
Thursday, June 18, 2026 | 1:00 PM - 2:00 PM CT
From Molecule to Medication: Integrating Menin Inhibitors in AML Practice
Friday, June 19, 2026 | 7:00 AM - 8:00 AM CT
Not All Bispecifics Are Equal: Mechanism-Based Approaches to Selection and Management in Oncology Practice
Thursday, June 18, 2026 | 7:00 AM - 8:00 AM CT
The Expanding Psoriasis Treatment Landscape: Leveraging the Pharmacist's Role in Patient Care to Improve Access and Outcomes for TYK Inhibitors
1.5 Credit / Dermatology, Immunology
From Crisis Aversion to Cost Reduction - Managed Care Insights on Enhancing Ketone Monitoring for Diabetic Ketoacidosis Prevention
3.0 Credits / Endocrinology, Diabetes & Metabolism
Stimulant Stewardship: A Pharmacist’s Guide to ADHD Prescribing During Drug Shortages
Monday, June 15, 2026 | 1:00 PM & 8:00 PM EDT
From Evidence to Access: Integrating SGLT2 Inhibitors Across the Cardiorenal-Metabolic Continuum
Thursday, June 25, 2026 | 1:00 PM & 8:00 PM ET
Homeopathy in Oncology Supportive Care: The Pharmacist’s Role in Integrating Patient-Centered Strategies for Chemotherapy-Related Symptom Management (Pharmacy Technician Credit)
2.0 Credits / Oncology
Homeopathy in Oncology Supportive Care: The Pharmacist’s Role in Integrating Patient-Centered Strategies for Chemotherapy-Related Symptom Management (Pharmacist Credit)
2.0 Credits / Oncology
Optimizing Outcomes in Hereditary Angioedema: Managed Care Approaches to Diagnosis, Treatment, and Patient Quality of Life
1.5 Credit / Immunology
Integrating Therapeutic Advances and Value-Based Models in Myasthenia Gravis Management
1.5 Credit / Neurology
Optimizing HER2-Targeted Therapies in Non-Small Cell Lung Cancer: A Pharmacist’s Guide to Biomarker Testing, Therapeutic Selection, and Toxicity Management
1.5 Credit / Oncology, Lung Cancer
Optimizing Cardiorenal-Metabolic Health: A Managed Care Guide to Integrating SGLT2 Inhibitor Therapy
1.5 Credit / Endocrinology, Diabetes & Metabolism
A Managed Care Perspective on Hard-to-Control Hypertension: Understanding the Risks and Challenges in Uncontrolled and Resistant Hypertension
1.5 Credit / Cardiology
New Frontiers in Hyperkalemia Care: The Role of Managed Care Professionals and Novel Potassium Binders
1.5 Credit / Nephrology
Improving Patient Outcomes in Fibrosing Interstitial Lung Diseases: Clinical and Managed Care Perspectives on the Evolving Landscape
1.5 Credit / Pulmonology/Respiratory
Breaking Barriers in Myelofibrosis Management: Optimizing Today, Preparing for Tomorrow
1.0 Credit / Hematologic Cancer, Hematology
From Biomarkers to Better Outcomes: The Impact of Immunotherapy on the Endometrial Cancer Landscape
1.5 Credit / Women’s Health, Gynecologic Cancer, Oncology
Uncomplicating the Complications of Systemic Lupus Erythematosus for Managed Care: A Focus on Nephritis
1.5 Credit / Rheumatology
Strategic HIV Management: Differentiating New Antiretrovirals and Designing Targeted Care Models
1.5 Credit / Infectious Disease
Aligning Clinical Evidence With Managed Care Decision-Making in the Evolving Myelofibrosis Treatment Landscape
1.5 Credit / Hematologic Cancer, Hematology
Redefining Value in Transthyretin Amyloidosis Cardiomyopathy Care: Innovations in Diagnosis, Treatment, and Access
1.5 Credit / Cardiology
High-Stakes Access: Aligning Managed Care Policy With the Urgency of Treatment in Duchenne Muscular Dystrophy
1.5 Credit / Neurology
Next-Generation Lipid Management: Elevating Outcomes Through Managed Care Strategies
1.5 Credit / Cardiology
Evolving Therapeutic Targets in Small Cell Lung Cancer: Updates and Insights for Managed Care
1.5 Credit / Lung Cancer
Improving Outcomes in Lipid Management: Aligning Managed Care Policy With Emerging Guideline Updates and Non-Statin Therapeutic Advances
Tuesday, May 26, 2026 | 1:00 PM & 7:00 PM EDT Thursday, June 4, 2026 | 1:00 PM & 7:00 PM EDT Tuesday...
The Right Regimen, the Right Workflow: Immunotherapy Insights for Advanced Non-Small Cell Lung Cancer in the Absence of Targetable Mutations
1.0 Credit / Oncology
Doubling Down in Non-Hodgkin Lymphoma: Pharmacy-Driven Strategies to Ensure Bispecific Antibody Use Is a Sure Bet
1.0 Credit / Oncology
Quad Goals: Optimizing Efficacy, Safety, and Workflow in Newly Diagnosed Multiple Myeloma
1.0 Credit / Oncology